Abstract:Deoxyschizandrin is an active lignin ingredient originating from Schisandra chinensis (Turcz.) Baill or Schisandrae Sphenantherae Fructus. In the present study, a novel and efficient strategy was developed for the in vivo screening and identification of deoxyschizandrin metabolites using ultra high performance liquid chromatography combined with triple TOF mass spectrometry (UPLC-TOF/MS/MS). This strategy was characterized by the following: a novel and unique multiple mass defect filter (MMDF) combined with an on-line data acquisition method that is dependent on dynamic background subtraction (DBS) was developed to trace all of the probable metabolites of deoxyschizandrin. The MMDF and DBS methods could trigger an IDA scan for the low-level metabolites that are masked by background noise and endogenous components. A combination of data processing methods including extracted ion chromatography (XIC), mass defect filtering (MDF), product ion filtering (PIF) and neutral loss filtering (NLF) were employed to identify the metabolites of deoxyschizandrin. Next, the structures of the metabolites were elucidated based on an accurate mass measurement, the fragmentation patterns of the parent drug and relevant drug bio-transformation knowledge. Finally, an important parameter ClogP was used to estimate the retention time of isomers. Based on the proposed strategy, 51 metabolites (including 49 phase I and 2 phase II metabolites) were identified in rats after the oral administration of deoxyschizandrin. Among these metabolites, 41 metabolites were characterized in the rat urine, and 28 metabolites were identified in the rat bile. The results indicated that oxidization was the main metabolic pathway and that the methoxy group and the biphenyl cyclooctene were the metabolic sites. Conjugation with sulfate and cysteine groups produced two phase-II metabolites. This study firstly reported the description of deoxyschizandrin metabolism in vivo. This study provided a practical strategy for rapidly screening and identifying metabolites, and this methodology can be widely applied for the structural characterization of the metabolites of other compounds.

Rapid Determination and Pharmacokinetics Study of Lignans in Rat Plasma after Oral Administration of Schisandra Chinensis Extract and Pure Deoxyschisandrin

Analysis of lignans in Schisandra chinensis and rat plasma by high-performance liquid chromatography diode-array detection, time-of-flight mass spectrometry and quadrupole ion trap mass spectrometry.

Bioanalytical Assay Development and Validation for Simultaneous Quantification of Five Schisandra Lignans in Rat Primary Hepatocytes Based on Lc-Ms/Ms: Application to A Real-Time Uptake Study for Schisandra Lignan Extract

Rapid Determination of Lignans in Schisandra chinensis by Supramolecular Solvent (SUPRAS)-Based Extraction and High-Performance Liquid Chromatography–Tandem Mass Spectrometry (HPLC-MS)

Pharmacokinetic Comparisons of Schizandrin after Oral Administration of Schizandrin Monomer, Fructus Schisandrae Aqueous Extract and Sheng-Mai-San to Rats.

Metabolic Rates and Metabolites of Three Lignans in Schisandra Chinensis (turcz.) Baill in Rat Liver Microsomes

Investigation of Pharmacokinetics, Tissue Distribution and Excretion of Schisandrin B in Rats by HPLC-MS/MS.

Simultaneous Determination of Three Major Lignans in Rat Plasma by LC-MS/MS and Its Application to a Pharmacokinetic Study after Oral Administration of Diphylleia Sinensis Extract.

Identification of Metabolites of Deoxyschizandrin in Rats by UPLC–Q-TOF-MS/MS Based on Multiple Mass Defect Filter Data Acquisition and Multiple Data Processing Techniques

Simultaneous Quantification of Five Lignans from Schisandra Chinensis in Various Tissues of Rats

Identification and quantification of baicalein, wogonin, oroxylin A and their major glucuronide conjugated metabolites in rat plasma after oral administration of Radix scutellariae product.

Study on the Plasma Protein Binding Rate of Schisandra Lignans Based on the Lc-It-Tof/Ms Technique with Relative Quantitative Analysis

Characterization of lignans in Schisandra chinensis oil with a single analysis process by UPLC-Q/TOF-MS

LC Analysis of Lignans from Schisandra Sphenanthera Rehd. Et Wils.

Application of Ultrahigh-Performance Liquid Chromatography Coupled with Mass Spectrometry for Analysis of Lignans and Quality Control of Fructus Schisandrae Chinensis

Pharmacokinetics and liver uptake of three Schisandra lignans in rats after oral administration of liposome encapsulating β-cyclodextrin inclusion compound of Schisandra extract

Pharmacokinetic Study of Schisanhenol Via Femoral Intravenous Administration in Rats

An LC-MS/MS method for the simultaneous determination of chlorogenic acid, forsythiaside A and baicalin in rat plasma and its application to pharmacokinetic study of shuang-huang-lian in rats

Simultaneous determination of six phenolic constituents of Danshen injection in rat plasma by LC-ESI-MS and its application to a pharmacokinetic study.

Simultaneous determination of five lignan constituents of Wuzhi capsule in rat plasma by LC-MS/MS: application to pharmacokinetic study.

Simultaneous Determination of Lignans in Different Tissues in an Alzheimer’s Disease Rat Model by HPLC-MS/MS